Media ReleasesINOVIQ

View All INOVIQ News

INOVIQ - Successful completion of Share Purchase Plan


-- IIQ successfully completed its share purchase plan with applications totalling A$7.293 million, exceeding its initial target of A$2 million.
-- Directors exercised discretion to accept allocations to the maximum of A$2.379 million and scale back thereafter on a pro-rata basis.
-- Total capital raised of A$9.379 million under both the SPP and recent placement (A$7 million) to institutional and sophisticated investors.
-- Both the Placement and SPP provided investors with one free quoted option for every two new Shares issued. The exercise price of each option is set at $1.00 and will expire at 5.00pm (Melbourne time) on 8 July 2026.
-- INOVIQ now has a pro forma cash balance of approximately A$14.489 million.
-- Funds will be used to advance the commercialisation of EXO-NET research tools and SubB2M breast and ovarian cancer monitoring tests, progress development of pipeline diagnostics and expedite research of high-value cancer therapeutics.

INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company) is pleased to announce the successful completion of the share purchase plan (SPP) announced on 12 June 2024, with applications accepted for A$2.379 million. The Company was seeking to raise up to A$2 million through the SPP with the capacity for oversubscriptions of up to A$0.4 million at the discretion of the Company (which represented the Company's maximum placement capacity).

Given the strong support (A$7.293 million in applications received in total) resulting in significant oversubscription for the SPP by eligible shareholders, the Board exercised its discretion to accept oversubscriptions of A$0.379 million. All SPP applicants are being granted a minimum application of $1,000, scaled back on a pro rata basis thereafter based on the applicant’s shareholding at record date.

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?